-
公开(公告)号:US5594104A
公开(公告)日:1997-01-14
申请号:US384492
申请日:1995-02-06
Applicant: Margret B. Basinski , Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , Brigitte E. Schoner , James E. Shields , David L. Smiley
Inventor: Margret B. Basinski , Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , Brigitte E. Schoner , James E. Shields , David L. Smiley
IPC: A61K38/00 , C07K14/575 , C07K7/00 , C07K7/10
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
公开(公告)号:US5580954A
公开(公告)日:1996-12-03
申请号:US381057
申请日:1995-01-31
Applicant: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
Inventor: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
IPC: A61K38/00 , C07K14/575 , C07K14/00
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
公开(公告)号:US5532336A
公开(公告)日:1996-07-02
申请号:US381034
申请日:1995-01-31
Applicant: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
Inventor: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
IPC: A61K38/00 , C07K14/575 , C07K14/00
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
公开(公告)号:US4087390A
公开(公告)日:1978-05-02
申请号:US763944
申请日:1977-02-02
Applicant: James E. Shields
Inventor: James E. Shields
IPC: A61K38/00 , C07K14/655 , C07C103/52 , A61K37/00 , C08L89/00
CPC classification number: C07K14/6555 , A61K38/00 , Y10S514/806 , Y10S930/16 , Y10S930/28
Abstract: The tetradecapeptides ##STR1## in which Y is L-Asn or L-Ala are described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptides. These tetradecapeptides as well as their pharmaceutically-acceptable acid addition salts exhibit various activities including inhibition of the release of gastric acid.
Abstract translation: 其中Y是L-Asn或L-Ala的十四肽“IMAGE”以及相应的无毒的药学上可接受的酸加成盐以及可用于合成十四肽的中间体。 这些十四肽及其药学上可接受的酸加成盐显示出各种活性,包括抑制胃酸的释放。
-
公开(公告)号:US5574133A
公开(公告)日:1996-11-12
申请号:US381049
申请日:1995-01-31
Applicant: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
Inventor: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
IPC: A61K38/00 , C07K14/575 , C07K7/00 , C07K7/10
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
公开(公告)号:US5563245A
公开(公告)日:1996-10-08
申请号:US381163
申请日:1995-01-31
Applicant: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
Inventor: Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , James E. Shields , David L. Smiley
IPC: A61K38/00 , C07K14/575 , C07K7/10
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
7.
公开(公告)号:US5514646A
公开(公告)日:1996-05-07
申请号:US57201
申请日:1993-05-05
Applicant: Ronald E. Chance , Richard D. DiMarchi , Bruce H. Frank , James E. Shields
Inventor: Ronald E. Chance , Richard D. DiMarchi , Bruce H. Frank , James E. Shields
CPC classification number: C07K14/62 , C07K14/622 , A61K38/00 , A61K9/0043
Abstract: Analogs of human insulin modified at position 29 of the B chain thereof and, optionally, at other positions, have modified physico-chemical and pharmacokinetic properties and are useful in the treatment of hyperglycemia.
Abstract translation: 在其B链的29位和任选地在其它位置修饰的人胰岛素的类似物具有改变的物理化学和药代动力学性质,并且可用于治疗高血糖症。
-
公开(公告)号:US4199501A
公开(公告)日:1980-04-22
申请号:US965536
申请日:1978-11-20
Applicant: James E. Shields
Inventor: James E. Shields
IPC: A61K38/00 , C07K14/655 , C07C103/52 , A61K37/00
CPC classification number: C07K14/6555 , A61K38/00 , Y10S514/806 , Y10S930/16
Abstract: Tetradecapeptides of the formula ##STR1## wherein X is H-Ala-D-Ala, H-D-Ala-Gly, or H-D-Val-Gly, and X.sup.1 is Phe or Cha, or a non-toxic pharmaceutically acceptable acid addition salt thereof, inhibit the secretion of growth hormone without materially inhibiting the secretion of glucagon or insulin. Intermediates and processes for making the tetradecapeptides are also described.
Abstract translation: 其中X是H-Ala-D-Ala,HD-Ala-Gly或HD-Val-Gly,X1是Phe或Cha或其无毒的药学上可接受的酸加成盐的式(I)的十四肽, 抑制生长激素的分泌,而不会明显抑制胰高血糖素或胰岛素的分泌。 还描述了制备十四肽的中间体和方法。
-
公开(公告)号:US4061607A
公开(公告)日:1977-12-06
申请号:US709465
申请日:1976-07-28
Applicant: James E. Shields
Inventor: James E. Shields
IPC: C07K14/575 , A61K38/00 , C07K14/655 , C08L67/00 , C07C103/52
CPC classification number: C07K14/6555 , A61K38/00 , Y10S930/16 , Y10S930/28
Abstract: The tetradecapeptides ##STR1## in which Y is L-Cha, L-Leu, or D-Phe are described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptides. These tetradecapeptides as well as their pharmaceutically-acceptable acid addition salts inhibit the release of growth hormone.
Abstract translation: 其中Y是L-Cha,L-Leu或D-Phe的十四肽“IMAGE”以及相应的无毒的药学上可接受的酸加成盐以及可用于合成十四肽的中间体进行了描述。 这些十四肽及其药学上可接受的酸加成盐抑制生长激素的释放。
-
公开(公告)号:US5605886A
公开(公告)日:1997-02-25
申请号:US442916
申请日:1995-05-17
Applicant: Margret B. Basinski , Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , Brigitte E. Schoner , James E. Shields , David L. Smiley
Inventor: Margret B. Basinski , Richard D. DiMarchi , David B. Flora , William F. Heath, Jr. , James A. Hoffmann , Brigitte E. Schoner , James E. Shields , David L. Smiley
IPC: C12N15/09 , A61K38/00 , A61P3/00 , A61P3/08 , A61P3/10 , C07K14/47 , C07K14/575 , C12P21/02 , C12R1/19
CPC classification number: C07K14/5759 , A61K38/00
Abstract: The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
-
-
-
-
-
-
-
-
-